sb 239063 has been researched along with Alloxan Diabetes in 4 studies
SB 239063: structure in first source
SB-239063 : A member of the class of imidazoles carrying 4-hydroxycyclohexyl, 4-fluorophenyl and 2-methoxypyrimidin-4-yl substituents at positions 1, 4 and 5 respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agthong, S | 2 |
| Tomlinson, DR | 3 |
| Price, SA | 2 |
| Middlemas, AB | 1 |
| Gardiner, NJ | 1 |
| Duran-Jimenez, B | 1 |
| Zeef, LA | 1 |
| Obrosova, IG | 1 |
| Riad, A | 1 |
| Unger, D | 1 |
| Du, J | 1 |
| Westermann, D | 1 |
| Mohr, Z | 1 |
| Sobirey, M | 1 |
| Dorenkamp, M | 1 |
| Schultheiss, HP | 1 |
| Tschöpe, C | 1 |
4 other studies available for sb 239063 and Alloxan Diabetes
| Article | Year |
|---|---|
Inhibition of p38 MAP kinase corrects biochemical and neurological deficits in experimental diabetic neuropathy.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; Enzyme Inhi | 2002 |
Mitogen-activated protein kinase p38 mediates reduced nerve conduction velocity in experimental diabetic neuropathy: interactions with aldose reductase.
Topics: Aldehyde Reductase; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Enzyme Activati | 2004 |
Thioredoxin interacting protein is increased in sensory neurons in experimental diabetes.
Topics: Animals; Antioxidants; Blotting, Western; Carrier Proteins; Cell Cycle Proteins; Cells, Cultured; Di | 2006 |
Chronic inhibition of p38MAPK improves cardiac and endothelial function in experimental diabetes mellitus.
Topics: Animals; Diabetes Mellitus, Experimental; Endothelium, Vascular; Imidazoles; Intercellular Adhesion | 2007 |